-- Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., has initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets to the consumer level due to the detection of trace amount of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. (US Food Recalls) More
Recon: Merck to Buy Peloton for $1.1B to Boost Cancer Pipeline Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Merck agrees $1bn deal to buy biopharmaceutical ...
Posted on 21 May 2019 | 2:00 am | Google News
We're only three months into the year, and the FDA has already removed countless drugs, both over-the-counter and pharmaceutical, from the shelves.
Posted on 27 March 2019 | 2:00 am | Google News
Dozens of medications used to treat high blood pressure, including valsartan, losatran and irbersartan, have been recalled over the past several months as ...
Posted on 23 January 2019 | 5:48 am | Google News
Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products - Press Release Digital Journal
Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., has initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets ...
Posted on 18 January 2019 | 3:00 am | Google News
The FDA announced that more recalls of several drug products containing the active ingredient valsartan, commonly used to treat high BP and HF, are taking ...
Posted on 14 July 2018 | 2:00 am | Google News
Copyright © 2019 LastMinuteStuff.com